NCT01365949
Completed
Not Applicable
INI-1 Deletions in Ewing Sarcoma
ConditionsSarcoma
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Sarcoma
- Sponsor
- Children's Oncology Group
- Enrollment
- 40
- Primary Endpoint
- Frequency of INI1 protein loss in Ewing Sarcoma
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.
PURPOSE: This research trial studies biomarkers in tissue samples from patients with Ewing sarcoma.
Detailed Description
OBJECTIVES: * To determine the frequency of INI-1 protein loss in Ewing Sarcoma. OUTLINE: Previously collected tissue samples are analyzed for INI-1 protein loss by IHC and tissue microarray.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Frequency of INI1 protein loss in Ewing Sarcoma
Similar Trials
Completed
Not Applicable
Biomarkers in Patients With RhabdomyosarcomaSarcomaNCT01466283Children's Oncology Group20
Unknown
Not Applicable
Cancer Stem Cell Biomarkers as a Predictor of Response to Trastuzumab in Samples From Patients With Breast Cancer Previously Treated in the NSABP-B-31 TrialBreast CancerNCT01424865NSABP Foundation Inc1,874
Completed
Not Applicable
Studying Tumor Tissue Samples From Patients With Soft Tissue SarcomaSarcomaNCT00900341University of Arizona27
Completed
Not Applicable
DNA Analysis of Tumor Tissue From Patients With Acute Myeloid LeukemiaLeukemiaNCT00897936ECOG-ACRIN Cancer Research Group418
Completed
Not Applicable
Biomakers in Tissue Samples From Patients With Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck Previously Treated With Cisplatin With or Without CetuximabHead and Neck CancerNCT01192750ECOG-ACRIN Cancer Research Group79